CPM Is a Useful Cell Surface Marker to Isolate Expandable Bi-Potential Liver Progenitor Cells Derived from Human iPS Cells.
CPM Is a Useful Cell Surface Marker to Isolate Expandable Bi-Potential Liver Progenitor Cells Derived from Human iPS Cells.
复制标题
DOI:
10.1016/j.stemcr.2015.08.008
复制
发表时间:
2015-10-13
影响因子:
5.9
通讯作者:
Miyajima A
中科院分区:
文献类型:
--
作者:
Kido T;Koui Y;Suzuki K;Kobayashi A;Miura Y;Chern EY;Tanaka M;Miyajima A
To develop a culture system for large-scale production of mature hepatocytes, liver progenitor cells (LPCs) with a high proliferation potential would be advantageous. We have found that carboxypeptidase M (CPM) is highly expressed in embryonic LPCs, hepatoblasts, while its expression is decreased along with hepatic maturation. Consistently, CPM expression was transiently induced during hepatic specification from human-induced pluripotent stem cells (hiPSCs). CPM+ cells isolated from differentiated hiPSCs at the immature hepatocyte stage proliferated extensively in vitro and expressed a set of genes that were typical of hepatoblasts. Moreover, the CPM+ cells exhibited a mature hepatocyte phenotype after induction of hepatic maturation and also underwent cholangiocytic differentiation in a three-dimensional culture system. These results indicated that hiPSC-derived CPM+ cells share the characteristics of LPCs, with the potential to proliferate and differentiate bi-directionally. Thus, CPM is a useful marker for isolating hiPSC-derived LPCs, which allows development of a large-scale culture system for producing hepatocytes and cholangiocytes. CPM is a novel marker for hepatoblasts during liver development Self-renewing hiPSC-derived CPM+ LPCs exhibit bi-potency in vitro An efficient and convenient protocol for the generation of hiPSC-derived LPCs Miyajima, Kido, and colleagues identify CPM as a novel cell surface marker specific for liver progenitor cells (LPCs) in fetal liver. CPM+ LPCs can be isolated from hiPSC-derived immature liver cells, expanded, and differentiated to hepatocytes and cholangiocytes in vitro. CMP+ LPCs are useful for efficient large-scale production of hepatocytes and cholangiocytes.